These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dam mutants provide improved sensitivity and spatial resolution for profiling transcription factor binding. Szczesnik T; Ho JWK; Sherwood R Epigenetics Chromatin; 2019 Jun; 12(1):36. PubMed ID: 31196130 [TBL] [Abstract][Full Text] [Related]
3. Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. Frietze S; Wang R; Yao L; Tak YG; Ye Z; Gaddis M; Witt H; Farnham PJ; Jin VX Genome Biol; 2012 Sep; 13(9):R52. PubMed ID: 22951069 [TBL] [Abstract][Full Text] [Related]
4. The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells. Norton L; Chen X; Fourcaudot M; Acharya NK; DeFronzo RA; Heikkinen S Nucleic Acids Res; 2014 Dec; 42(22):13646-61. PubMed ID: 25414334 [TBL] [Abstract][Full Text] [Related]
5. Embryonic Program Activated during Blast Crisis of Chronic Myelogenous Leukemia (CML) Implicates a TCF7L2 and MYC Cooperative Chromatin Binding. Desterke C; Hugues P; Hwang JW; Bennaceur-Griscelli A; Turhan AG Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517078 [TBL] [Abstract][Full Text] [Related]
6. Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo. Zhao J; Schug J; Li M; Kaestner KH; Grant SF Diabetologia; 2010 Nov; 53(11):2340-6. PubMed ID: 20640398 [TBL] [Abstract][Full Text] [Related]
7. TCF7L2 is a master regulator of insulin production and processing. Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099 [TBL] [Abstract][Full Text] [Related]
8. Claudin-based barrier differentiation in the colonic epithelial crypt niche involves Hopx/Klf4 and Tcf7l2/Hnf4-α cascades. Lili LN; Farkas AE; Gerner-Smidt C; Overgaard CE; Moreno CS; Parkos CA; Capaldo CT; Nusrat A Tissue Barriers; 2016; 4(3):e1214038. PubMed ID: 27583195 [TBL] [Abstract][Full Text] [Related]
9. The Wnt Effector TCF7l2 Promotes Oligodendroglial Differentiation by Repressing Autocrine BMP4-Mediated Signaling. Zhang S; Wang Y; Zhu X; Song L; Zhan X; Ma E; McDonough J; Fu H; Cambi F; Grinspan J; Guo F J Neurosci; 2021 Feb; 41(8):1650-1664. PubMed ID: 33452226 [TBL] [Abstract][Full Text] [Related]
10. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway. Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810 [TBL] [Abstract][Full Text] [Related]
11. A context-specific cardiac β-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart. Iyer LM; Nagarajan S; Woelfer M; Schoger E; Khadjeh S; Zafiriou MP; Kari V; Herting J; Pang ST; Weber T; Rathjens FS; Fischer TH; Toischer K; Hasenfuss G; Noack C; Johnsen SA; Zelarayán LC Nucleic Acids Res; 2018 Apr; 46(6):2850-2867. PubMed ID: 29394407 [TBL] [Abstract][Full Text] [Related]
12. The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis. Ip W; Shao W; Chiang YT; Jin T Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1166-76. PubMed ID: 22967502 [TBL] [Abstract][Full Text] [Related]
13. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Norton L; Fourcaudot M; Abdul-Ghani MA; Winnier D; Mehta FF; Jenkinson CP; Defronzo RA Diabetologia; 2011 Dec; 54(12):3132-42. PubMed ID: 21901280 [TBL] [Abstract][Full Text] [Related]
14. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2. Duan B; Zhou X; Zhang X; Qiu F; Zhang S; Chen Y; Yang J; Wang J; Tan W Biochem Pharmacol; 2023 Dec; 218():115877. PubMed ID: 37879498 [TBL] [Abstract][Full Text] [Related]
15. Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation. Zhao C; Deng Y; Liu L; Yu K; Zhang L; Wang H; He X; Wang J; Lu C; Wu LN; Weng Q; Mao M; Li J; van Es JH; Xin M; Parry L; Goldman SA; Clevers H; Lu QR Nat Commun; 2016 Mar; 7():10883. PubMed ID: 26955760 [TBL] [Abstract][Full Text] [Related]
16. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants. Nome T; Hoff AM; Bakken AC; Rognum TO; Nesbakken A; Skotheim RI PLoS One; 2014; 9(3):e91264. PubMed ID: 24608966 [TBL] [Abstract][Full Text] [Related]
17. The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function. Chen X; Ayala I; Shannon C; Fourcaudot M; Acharya NK; Jenkinson CP; Heikkinen S; Norton L Diabetes; 2018 Apr; 67(4):554-568. PubMed ID: 29317436 [TBL] [Abstract][Full Text] [Related]
18. Wnt9a deficiency discloses a repressive role of Tcf7l2 on endocrine differentiation in the embryonic pancreas. Pujadas G; Cervantes S; Tutusaus A; Ejarque M; Sanchez L; García A; Esteban Y; Fargas L; Alsina B; Hartmann C; Gomis R; Gasa R Sci Rep; 2016 Jan; 6():19223. PubMed ID: 26771085 [TBL] [Abstract][Full Text] [Related]
19. The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells. Shao W; Szeto V; Song Z; Tian L; Feng ZP; Nostro MC; Jin T J Mol Endocrinol; 2018 Jul; 61(1):1-12. PubMed ID: 29678908 [TBL] [Abstract][Full Text] [Related]
20. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]